A Phase 1 Randomized, Double Blind (3rd Party Open), Placebo Controlled Combined Single And Multiple Dose Safety, Tolerability And Pharmacokinetics Study Of Orally Administered PF-04805712 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2010
At a glance
- Drugs PF 4805712 (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- 23 Nov 2010 Planned end date changed from 1 Mar 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 23 Nov 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 16 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.